Loading...
XSHE002107
Market cap362mUSD
Jan 06, Last price  
4.60CNY
1D
6.48%
1Q
-6.69%
Jan 2017
-51.55%
IPO
71.17%
Name

Shandong Wohua Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002107 chart
P/E
45.18
P/S
2.97
EPS
0.10
Div Yield, %
0.00%
Shrs. gr., 5y
0.90%
Rev. gr., 5y
2.92%
Revenues
894m
-11.87%
91,419,467111,328,167122,675,508129,448,668196,541,142172,195,51290,920,639149,028,621209,606,772255,597,771315,307,987468,923,668562,845,617726,646,140774,415,740860,290,5351,006,081,515942,674,5531,014,818,455894,314,711
Net income
59m
-45.27%
23,132,88928,436,53831,502,67735,419,51953,638,15552,373,10907,432,7798,340,37310,621,28836,547,99971,365,66948,809,43057,031,87845,651,51895,801,508178,880,358163,392,002107,385,86558,767,086
CFO
129m
-30.23%
33,766,14513,009,80846,053,65510,455,38235,585,538001,361,93933,858,42015,154,91126,577,326132,819,71472,909,796123,881,287107,883,59131,655,284196,577,975200,119,233185,258,732129,246,864
Dividend
May 24, 20240.25 CNY/sh

Profile

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.
URL
https://www.wohua.cn/
IPO date
Jan 24, 2007
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
894,315
-11.87%
1,014,818
7.65%
Cost of revenue
689,838
839,383
Unusual Expense (Income)
NOPBT
204,476
175,436
NOPBT Margin
22.86%
17.29%
Operating Taxes
8,011
20,907
Tax Rate
3.92%
11.92%
NOPAT
196,466
154,528
Net income
58,767
-45.27%
107,386
-34.28%
Dividends
(150,074)
Dividend yield
4.19%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
401
1,007
Long-term debt
401
801
Deferred revenue
20,726
Other long-term liabilities
18,651
1,287
Net debt
(418,677)
(295,582)
Cash flow
Cash from operating activities
129,247
185,259
CAPEX
(2,715)
Cash from investing activities
(2,622)
Cash from financing activities
(3,554)
FCF
261,748
246,824
Balance
Cash
401,100
278,289
Long term investments
18,378
19,101
Excess cash
374,763
246,649
Stockholders' equity
833,478
789,790
Invested Capital
477,767
535,222
ROIC
38.79%
25.95%
ROCE
23.86%
22.31%
EV
Common stock shares outstanding
587,671
577,210
Price
6.07
-2.10%
6.20
-13.08%
Market cap
3,567,162
-0.32%
3,578,700
-13.08%
EV
3,176,696
3,326,408
EBITDA
237,699
210,763
EV/EBITDA
13.36
15.78
Interest
129
26
Interest/NOPBT
0.06%
0.01%